Ronald W. Chapman II, chair of Chapman Law Group’s White Collar Defense & Government Investigations practice group, will be speaking on controlled substance compliance plans and preparing for DEA inspections at an upcoming virtual conference.
The American Conference Institute’s “Controlled Substances: Regulation, Litigation, and Enforcement,” which is set for July 20-22, 2020, is an annual forum on the latest regulatory and legal developments in the controlled substance industry. The conference is for pharmaceutical stakeholders and healthcare attorneys, and it includes updates from the DOJ, FDA and DEA on state and federal enforcement initiatives.
On July 20, Chapman will lead the “Compliance Think Tank: Building and Enhancing an Effective Controlled Substances Compliance Program” workshop. In the seminar, Chapman will explain the best practices for designing a comprehensive handbook on the latest regulatory developments that influence risk management, how to maintain compliance, and avoiding unforeseen fines and/or federal charges.
Then, on July 21, Chapman is a featured panelist for “DEA Site Visit Checklist: Tailoring Inspection Strategies for Every Link of the Supply Chain.” The discussion will examine procedures, inventory control concerns, recordkeeping, and security requirements for unannounced DEA visits to manufacturer, distributor and retail pharmacy sites.
Chapman’s national criminal law practice includes representing physicians, pain management specialists, and pharmacists in healthcare fraud, DEA compliance, and drug trafficking matters. He is regularly invited by state and national medical societies and criminal defense organizations to serve as an expert at seminars on Medicare and Medicaid fraud, unlawful prescribing, and government investigations.
Our attorneys serve healthcare providers throughout the U.S.: in Michigan (including Detroit, Dearborn, Troy, Ann Arbor and Grand Rapids), Florida (Miami, Jacksonville, Tampa, Orlando and West Palm Beach), and nationally in regions including Los Angeles and Southern California, Chicago, Pittsburgh, and Washington, D.C.
We have extensive experience in defending national health professionals faced with criminal charges, including:
We represent licensed medical professionals, including:
Our offices are in Detroit; Miami and Sarasota, Florida; Los Angeles/Southern California; and Chicago. Contact us today to learn more.
Ronald W. Chapman II, LL.M.
Shareholder
Chairperson of White Collar Defense & Government Investigations
Michigan Office
1441 W. Long Lake Road, Suite 310
Troy, MI 48098
Phone: (248) 644-6326
In representing hundreds of doctors, specialty physicians and pain management specialists on federal healthcare fraud and drug trafficking charges, we’ve been able to glean from the DOJ litigation playbook . Here are 10 secrets we’ve found — and how we tear them down at trial.
Our healthcare criminal lawyers have seen, in these situations, pharmacists and physicians also get their professional medical licenses suspended or revoked, as well as their DEA registration.
If a physician is excluded from Medicare/Medicaid because he/she accepted a kickback, does this mean he/she could be denied DEA registration in the future? Not necessarily.
The Drug Enforcement Administration (DEA) office of diversion uses “red flag” indicators to determine which doctors should be the subject of increased scrutiny, undercover visits,
Michigan OFFICE
1441 W Long Lake Road
Suite 310
Troy, MI 48098
T. 248.644.6326
F. 248.644.6324
FLORIDA OFFICES
6841 Energy Court
Sarasota, FL 34240
T. 941.893.3449
1001 Brickell Bay Drive
Suite 1714
Miami, FL 33131
T. 305.712.7177
Practice Areas
Attorneys
© CHAPMAN LAW GROUP. ALL RIGHTS RESERVED
Send this to a friend
